Health Insurers Call for Greater FDA Authority

Washington Drug Letter
KEYWORDS FDA / IndustryNews
A A
The FDA should have more power to force manufacturers to make labeling changes and conduct postmarketing clinical studies, a trade association of leading insurers said in recent recommendations.

To View This Article:

Login